This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Medizone International Announces Successful Production Of AsepticSure Hospital Disinfection System

Stocks in this article: MZEI SMTX

SAN FRANCISCO, April 10, 2012 /PRNewswire/ -- Medizone International, Inc. (MZEI:OB) (MZEI:QB) announced today that the first production unit of its AsepticSure disinfection technology has been successfully completed by its manufacturing partner, SMTC Corporation (NASDAQ:SMTX). 

Following performance confirmation testing of the initial unit, four additional units will immediately be manufactured for independent validation testing and subsequently placed into commercial service. The first five production units are expected to be delivered to Medizone by month's end.

"Our peer reviewed article in the AJIC and more recent recognition in Geneva for Innovation Excellence marked the beginning of a series of amazing achievements for Medizone," stated Dr Michael Shannon, President and Director of Medical Affairs.

"A combination of scientific, developmental and technological advancements made by the company over the past 12 months has seen us arrive at the brink of an exciting new era in Medizone's history.

"I have no doubt whatsoever that AsepticSure is poised to become the gold standard for hospital disinfection," said Shannon.

Medizone International's Chairman and CEO, Edwin Marshall commented: "In addition to successfully initiating production, we're pleased to announce that Health Canada recently informed us that they will not regulate AsepticSure as either a medical device or disinfectant.  Additionally, they will not require a new DIN (drug identification number) for the AsepticSure catalyst.

"The Company views this ruling by Health Canada in the most favorable light. It means that following standard validation testing of the initial production units over the coming 4 weeks, the Company may then begin commercial sales of AsepticSure in Canada.  

"For Medizone to successfully develop and launch such a superior, fast-acting (green) disinfection technology capable of consistently producing 100% bacterial kills on both hard and soft surfaces without leaving any residual residue... it's an amazing achievement. Our R&D, science, regulatory, patent and production teams have done an outstanding job. I couldn't be more proud of them."

In related news, Medizone's regulatory team has also submitted a Request for Designation in the US, to the FDA. 

For press information on Medizone International, please contact:

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,059.34 +5.63 0.03%
S&P 500 2,093.14 +4.37 0.21%
NASDAQ 4,811.9050 +5.0460 0.10%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs